| |
|
|
|
CymaBay Therapeutics Inc.  
|
|
5.75 -0.26 (-0.04%) |
09-13 16:00 |
|
Open: |
6.08 |
Pre close: |
6.01 |
Target:
|
7.16 
|
|
High: |
6.1576 |
Low: |
5.74 |
Resistance:
|
6.13
6.56
|
|
Volume: |
701,974 |
Market Cap: |
395M |
Support:
|
5.43
4.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.09
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
5.88 |
Signal(12,26,9): |
-0.08  |
|
MA(100): |
8.34 |
Stochastic Oscillator |
%K(14,3):
|
51.62 |
|
MA(250): |
9.62 |
%D(3): |
70.39 |
|
Average Volume(K) |
3-Month: |
68438
|
52-Week |
High:
|
14.00 |
|
10-Days: |
47686 |
Low: |
4.82 |
|
RSI |
RSI(14):
|
43.37 |
Change(%): |
-53.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.380 |
Return on Equity (ttm) |
-39.1 |
Shares Out. (M) |
68.70 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-24.3 |
Shares Float (M) |
50.59 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.74 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
88.51 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.637 |
Shares Short (K) |
8480 |
|
Book Value (p.s.) |
3.440 |
EBITDA (p.s.) |
-1.328 |
P/E |
-4.17 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.67 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-82.32 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-55.39 |
P/CF |
-4.80 |
|
|
|
|
|
|
